Key result
Ventricular pulsed field ablation demonstrates favorable acute and long-term safety and efficacy across clinical studies.
Why the study?
Although atrial pulsed field ablation (PFA) has shown well-demonstrated success, clinical experience with ventricular applications of PFA remains in its infancy, prompting a systematic synthesis of available preclinical and clinical evidence.
What are the acute and long-term safety and efficacy outcomes of ventricular pulsed field ablation in preclinical models and patients with ventricular arrhythmias?
Systematic Review (n=434)
Yes
What are the acute and long-term safety and efficacy outcomes of ventricular pulsed field ablation in preclinical models and patients with ventricular arrhythmias?
This systematic review of 111 preclinical and clinical studies (434 patients) demonstrates that ventricular pulsed field ablation yields generally favorable acute and long-term outcomes for ventricular tachycardia and premature ventricular complexes, though safety constraints require further exploration.
Pulsed field ablation may be considered for refractory ventricular arrhythmias; extends atrial data but leaves open need for randomized safety and efficacy trials.
Pulsed field ablation (PFA) is a paradigm shift in the field of cardiac electrophysiology. The well-demonstrated success with atrial PFA is generating enthusiasm for ventricular applications of PFA, for which the clinical experience is still in its infancy, however. This study is a systematic review and critical appraisal of the published preclinical and clinical evidence on ventricular PFA, involving a total of 111 primary articles (55 preclinical and 56 clinical). An increasing number of PFA platforms and catheters are being used in the ventricle in clinical practice. This appraisal evaluates the impact of ablation parameters in association with lesion depth and volume, and synthesises the available studies of safety and efficacy outcomes for ablation of ventricular tachycardia and premature ventricular complexes with PFA, as reported in case reports and case series from around the world. The cumulative published evidence amounts to a total of 434 patients ablated with PFA for ventricular arrhythmias, with generally favourable acute and long-term results, while the understanding of safety constraints continues to be explored.
No takes yet. Share an insight, caveat, or question.
Gómez et al. (2026) conducted a systematic review in Ventricular arrhythmias (ventricular tachycardia and premature ventricular complexes) (n=434). Ventricular pulsed field ablation (PFA) was evaluated on Safety and efficacy outcomes, lesion depth and volume. Ventricular pulsed field ablation demonstrated generally favourable acute and long-term results across 434 patients in 111 preclinical and clinical studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: